Regulus Therapeutics

$1.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-7.38%) Today

-$0.01 (-0.72%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RGLS and other stocks, options, and ETFs commission-free!

About RGLS

Regulus Therapeutics Inc. Common Stock, also called Regulus Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs.

CEO

Joseph P. Hagan

Employees

Headquarters

San Diego, California

Founded

2007

Market Cap

99.39M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

780.32K

High Today

$1.49

Low Today

$1.36

Open Price

$1.46

Volume

695.41K

52 Week High

$2.32

52 Week Low

$0.4222

RGLS Earnings

-$0.26

-$0.17

-$0.09

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 10, After Hours